Growing community of inventors

Shanghai, China

Junmiao Li

Average Co-Inventor Count = 5.39

ph-index = 1

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 1

Junmiao LiYunfu Luo (4 patents)Junmiao LiMaoyi Lei (4 patents)Junmiao LiShuhui Chen (2 patents)Junmiao LiYu Xu (2 patents)Junmiao LiXin Li (1 patent)Junmiao LiChen Bo Li (1 patent)Junmiao LiChen Li (11 patents)Junmiao LiKunlun He (1 patent)Junmiao LiChunlei Liu (1 patent)Junmiao LiGuoli Zhang (1 patent)Junmiao LiJinghong Dong (1 patent)Junmiao LiZeyu Zhang (1 patent)Junmiao LiRan Wei (1 patent)Junmiao LiXiaojian Gao (1 patent)Junmiao LiYiwei Wang (1 patent)Junmiao LiJunmiao Li (4 patents)Yunfu LuoYunfu Luo (33 patents)Maoyi LeiMaoyi Lei (9 patents)Shuhui ChenShuhui Chen (197 patents)Yu XuYu Xu (4 patents)Xin LiXin Li (191 patents)Chen Bo LiChen Bo Li (28 patents)Chen LiChen Li (11 patents)Kunlun HeKunlun He (6 patents)Chunlei LiuChunlei Liu (5 patents)Guoli ZhangGuoli Zhang (3 patents)Jinghong DongJinghong Dong (2 patents)Zeyu ZhangZeyu Zhang (2 patents)Ran WeiRan Wei (2 patents)Xiaojian GaoXiaojian Gao (1 patent)Yiwei WangYiwei Wang (1 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Shijiazhuang Sagacity New Drug Development Company, Ltd. (2 from 5 patents)

2. Medshine Discovery Inc. (1 from 65 patents)

3. Chinese Pla General Hospital (1 from 11 patents)

4. Wuxi Biocity Biopharmaceuticals Co., Ltd. (1 from 1 patent)

5. Wuxi Biocity Biopharmaceutics Co., Ltd. (5 patents)


4 patents:

1. 12297192 - Crystal form of pyrimidine sulfonamide compound and preparation method therefor

2. 11905276 - Bicyclic compound that acts as CRBN protein regulator

3. 11628168 - Medical application of pyrimidine sulfonamides derivatives

4. 11319305 - Pyrimidine sulfamide derivative and preparation method and medical application thereof

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/31/2025
Loading…